isoproterenol and omecamtiv mecarbil

isoproterenol has been researched along with omecamtiv mecarbil in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Anderson, RL; Baliga, R; Brejc, K; Cox, DR; Elias, KA; Finer, JT; Garard, M; Godinez, G; Hartman, JJ; Kass, DA; Katori, T; Kawas, R; Kraynack, E; Lee, KH; Lenzi, D; Lu, PP; Malik, FI; Morgan, BP; Morgans, DJ; Muci, A; Niu, C; Pierce, DW; Pokrovskii, M; Qian, X; Rodriguez, H; Sakowicz, R; Shen, YT; Suehiro, I; Sueoka, SH; Sylvester, S; Tochimoto, T; Valdez, C; Vatner, SF; Wang, W1
Gao, B; Qu, Y; Sutherland, W; Vargas, HM1

Other Studies

2 other study(ies) available for isoproterenol and omecamtiv mecarbil

ArticleYear
Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.
    Science (New York, N.Y.), 2011, Mar-18, Volume: 331, Issue:6023

    Topics: Actin Cytoskeleton; Actins; Adenosine Triphosphatases; Adenosine Triphosphate; Adrenergic beta-Agonists; Allosteric Regulation; Animals; Binding Sites; Calcium; Cardiac Myosins; Cardiac Output; Dogs; Female; Heart Failure, Systolic; Isoproterenol; Male; Myocardial Contraction; Myocytes, Cardiac; Phosphates; Protein Binding; Protein Conformation; Protein Isoforms; Rats; Rats, Sprague-Dawley; Urea; Ventricular Function, Left

2011
Effects of omecamtiv mecarbil on calcium-transients and contractility in a translational canine myocyte model.
    Pharmacology research & perspectives, 2020, Volume: 8, Issue:5

    Topics: Animals; Calcium Signaling; Dogs; Dose-Response Relationship, Drug; Fura-2; Heart Ventricles; Humans; Isoproterenol; Male; Models, Animal; Muscle Cells; Muscle Contraction; Sarcomeres; Urea

2020